Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
6,100
Employees6,100
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
6,100
Employees6,100

VRTX Key Statistics

Market cap
106.01B
Market cap106.01B
Price-Earnings ratio
29.33
Price-Earnings ratio29.33
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
$413.73
High today$413.73
Low today
$410.02
Low today$410.02
Open price
$410.93
Open price$410.93
Volume
91.84K
Volume91.84K
52 Week high
$519.88
52 Week high$519.88
52 Week low
$362.50
52 Week low$362.50

VRTX News

The Motley Fool 5h
The Smartest Growth Stock to Buy With $500 Right Now

Vertex isn't your run-of-the-mill biotech stock. Warren Buffett famously said that he and his investing managers "attempt to be fearful when others are greedy,...

The Smartest Growth Stock to Buy With $500 Right Now
Simply Wall St 13h
How FDA Recognition of Kidney Disease Therapies at Vertex Has Changed Its Investment Story

Vertex Pharmaceuticals recently announced progress across its kidney disease programs, including FDA Breakthrough Therapy Designation for povetacicept in IgA Ne...

How FDA Recognition of Kidney Disease Therapies at Vertex Has Changed Its Investment Story
Nasdaq 1d
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500

Key Points Investors have feared that U.S. import tariffs may hurt companies’ earnings growth -- and weigh on stock performance. The following two players not...

Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500

Analyst ratings

60%

of 35 ratings
Buy
60%
Hold
37.1%
Sell
2.9%

More VRTX News

Simply Wall St 2d
Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy?

Trying to decide what to do with Vertex Pharmaceuticals stock right now? You are far from alone. After all, over the past year, the company’s share price dipped...

Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy?
TipRanks 2d
Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline

Vertex Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst on October 3. Analyst Evan Seigerman from BMO Capital maintained a...

Nasdaq 5d
Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twi...

Validea Detailed Fundamental Analysis - VRTX
Benzinga 5d
ServiceNow, Vertex Pharmaceuticals And More: CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” on Thursday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he likes ServiceNow,...

ServiceNow, Vertex Pharmaceuticals And More: CNBC's 'Final Trades'
TipRanks 6d
Vertex Pharmaceuticals price target raised to $575 from $550 at Citi

Citi raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $575 from $550 and keeps a Buy rating on the shares. The firm upped the price target aft...

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.